Uncertainty Clouds Pharma Patent Validity As SCOTUS Ruminates On Amgen Case
Executive Summary
The pharma and biotech industry is waiting with bated breath for the decision from the US Supreme Court over a contentious case involving Amgen. The result of the SCOTUS decision could have a huge impact on drugmakers’ profits, commercial strategy, and industry innovation.